We appreciate the contribution of workers from the federal and state zoonosis programs of Centro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE), who participated in the workshop “Análisis de costo-efectividad del Programa Nacional de Vacunación Antirrábica de Perros” in CENAPRECE, Ciudad de México, during the week of May 15–20, 2016. We also want to highlight the support received from the Division of Global Migration and Quarantine (DGMQ) of the US Centers for Disease Control and Prevention (CDC), especially Margarita Elsa Villarino, and also to Jesse Blanton and Ryan Wallace of the Poxvirus and Rabies Branch, CDC, and Seonghye Jeon from the Health Economics and Modeling UNIT, CDC, for their technical support and suggestions in the development of this evaluation. Finally, we want to thank Nancy Armenta and Óscar Beltrán PhD’s excellent work in the development of this analysis, and Mariana Arellano, Daniela Islas, and many other people from CENAPRECE that were key to the development of this research.

Disclaimer
The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention (CDC).